Last reviewed · How we verify

NCT07249541: AIS

Hypermobility, Foot Posture, and Scoliosis Severity

Not yet recruiting Last updated 5 December 2025
What this trial tests

trial testing Assessment in Joint Hypermobility in 40 participants. Not yet recruiting.

Timeline
15 December 2025
Primary endpoint
15 March 2026
30 March 2026

Quick facts

Lead sponsorIstinye University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment40
Start date15 December 2025
Primary completion15 March 2026
Estimated completion30 March 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istinye University

Who can join

Adults 10 to 19, any sex, with Joint Hypermobility or Adolescent Idiopathic Scoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adolescent Idiopathic Scoliosis is a three-dimensional spinal deformity that may also affect joint mobility, lower limb alignment, and overall posture. Joint hypermobility and foot posture abnormalities, including pronation or supination, are commonly observed in adolescents and may contribute to postural imbalance or altered biomechanical loading. However, the relationship between hypermobility, foot posture, and the severity of scoliosis remains unclear. The aim of this study is to examine whether generalized joint hypermobility and foot posture characteristics are associated with Cobb angle severity in adolescents diagnosed with Adolescent Idiopathic Scoliosis. Hypermobility will be assessed using the Beighton Score, and foot posture will be evaluated with the Foot Posture Index. Understanding these associations may help clinicians better evaluate biomechanical factors related to scoliosis and guide future preventive or therapeutic approaches.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Assessment

Trials testing the same drug.

Other recruiting trials for Joint Hypermobility

Currently open trials in the same condition.

Other Istinye University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07249541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing